Nebulin – a giant sarcomeric protein – plays a pivotal role in skeletal muscle contractility by specifying thin filament length and function. Although mutations in the gene encoding nebulin (NEB) are a frequent cause of nemaline myopathy (NM), the most common non-dystrophic congenital myopathy, the mechanisms by which mutations in NEB cause muscle weakness remain largely unknown. To better understand these mechanisms, we have generated a mouse model in which Neb exon 55 is deleted (NebΔex55) to replicate a founder mutation seen frequently in NM patients with Ashkenazi Jewish heritage. NebΔex55 mice are born close to Mendelian ratios, but show growth retardation after birth. Electron microscopy studies show nemaline bodies – a hallmark feature of NM – in muscle fibers from NebΔex55 mice. Western blotting studies with nebulin-specific antibodies reveal reduced nebulin levels in muscle from NebΔExon55 mice, and immunofluorescence confocal microscopy studies with tropomodulin antibodies and phalloidin reveal that thin filament length is significantly reduced. In line with reduced thin filament length, the maximal force generating capacity of permeabilized muscle fibers and single myofibrils is reduced in NebΔex55 mice with a more pronounced reduction at longer sarcomere lengths. Finally, in NebΔex55 mice the regulation of contraction is impaired, as evidenced by marked changes in cross bridge cycling kinetics and by a reduction of the calcium sensitivity of force generation. A novel drug that facilitates calcium binding to the thin filament significantly augmented the calcium sensitivity of submaximal force to levels that exceed those observed in untreated control muscle. In conclusion, we have characterized the first nebulin-based NM model, which recapitulates important features of the phenotype observed in patients harboring this particular mutation, and which has severe muscle weakness caused by thin filament dysfunction.
Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy / Ottenheijm, Cac; Buck, D; de Winter, J; Ferrara, Claudia; Piroddi, Nicoletta; Tesi, Chiara; Jasper, R; Malik, F; Meng, F; Stienen, G; Beggs, Ah; Labeit, S; Poggesi, Corrado; Lawlor, M; Granzier, H.. - In: NEUROMUSCULAR DISORDERS. - ISSN 0960-8966. - STAMPA. - 23:(2013), pp. 786-786. [10.1016/j.nmd.2013.06.523]
Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy
FERRARA, CLAUDIA;PIRODDI, NICOLETTA;TESI, CHIARA;POGGESI, CORRADO;
2013
Abstract
Nebulin – a giant sarcomeric protein – plays a pivotal role in skeletal muscle contractility by specifying thin filament length and function. Although mutations in the gene encoding nebulin (NEB) are a frequent cause of nemaline myopathy (NM), the most common non-dystrophic congenital myopathy, the mechanisms by which mutations in NEB cause muscle weakness remain largely unknown. To better understand these mechanisms, we have generated a mouse model in which Neb exon 55 is deleted (NebΔex55) to replicate a founder mutation seen frequently in NM patients with Ashkenazi Jewish heritage. NebΔex55 mice are born close to Mendelian ratios, but show growth retardation after birth. Electron microscopy studies show nemaline bodies – a hallmark feature of NM – in muscle fibers from NebΔex55 mice. Western blotting studies with nebulin-specific antibodies reveal reduced nebulin levels in muscle from NebΔExon55 mice, and immunofluorescence confocal microscopy studies with tropomodulin antibodies and phalloidin reveal that thin filament length is significantly reduced. In line with reduced thin filament length, the maximal force generating capacity of permeabilized muscle fibers and single myofibrils is reduced in NebΔex55 mice with a more pronounced reduction at longer sarcomere lengths. Finally, in NebΔex55 mice the regulation of contraction is impaired, as evidenced by marked changes in cross bridge cycling kinetics and by a reduction of the calcium sensitivity of force generation. A novel drug that facilitates calcium binding to the thin filament significantly augmented the calcium sensitivity of submaximal force to levels that exceed those observed in untreated control muscle. In conclusion, we have characterized the first nebulin-based NM model, which recapitulates important features of the phenotype observed in patients harboring this particular mutation, and which has severe muscle weakness caused by thin filament dysfunction.File | Dimensione | Formato | |
---|---|---|---|
PosterDeleting....pdf
accesso aperto
Descrizione: Meeting Abstract
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
46.89 kB
Formato
Adobe PDF
|
46.89 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.